Buy when everybody is fearful and pessimistic, page-179

Wow...I am not baiting but this is an absolutely crazy proposition, in my opinion.

There is no way that A2M will ever reach $100 per share - which by the way would equate to a market capitalisation of $74.365B (yes - billion).

1. That would currently place it as the Top 8th stock on the ASX.




2. It would need to increase 5 times from the share price at its its zenith, or in fact 21.37 times from its present price.



3. Applying any metric the Financials are abysmall - this is simply the summary
SUMMARY



4. Continuing on financial theme

1. Last reported revenue was down 30% on prior year
2. Expenses were down 10%.
3. EBITDA was down from $505M to $124M


5. Perhaps the most detrimental one I have left to last is that A2M no longer have a proprietary moat as others are now offering products with the A2 beta-casein protein (to name BUBS as but one example).